磷脂醯膽鹼市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Phosphatidylcholine Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月30日 | 出版商:

Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球磷脂醯膽鹼市場在2023 年達到13 億美元，2024 年至2032 年將以6% 的複合年成長率成長，這得益於消費者健康意識的提高、製藥應用的進步以及膳食補充劑需求的不斷成長。隨著人們越來越重視自己的健康，他們尋求有效的補充劑來支持認知功能、肝臟健康和整體健康。此外，研究和技術的進步正在擴大磷脂醯膽鹼在藥物中的應用，並增強其治療潛力。健康意識和創新應用的融合使磷脂醯膽鹼成為不斷發展的健康領域的關鍵成分。

磷脂醯膽鹼產業根據來源、形式、應用和地區進行細分。

2023 年，大豆市場規模為 5.783 億美元，在其廣泛供應和成本效益的推動下，2024 年至 2032 年將以 6.5% 的複合年成長率成長。大豆磷脂醯膽鹼因其在膳食補充劑和藥品中的成熟應用而受到青睞，使其成為製造商的熱門選擇。隨著注重健康的消費者擴大尋求價格實惠且有效的補充劑，對大豆製品的需求持續成長。此外，對非基因改造和無過敏原成分的日益重視進一步增強了大豆磷脂醯膽鹼的吸引力，鞏固了其在市場上的主導地位。

藥品領域在各種治療應用中發揮關鍵作用，其銷售額於 2023 年擴大至 4.773 億美元，2024 年至 2032 年複合年成長率為 6.8%。磷脂醯膽鹼因其在針對肝臟健康、認知功能和細胞膜完整性的配方中的高純度和有效性而得到認可。隨著對創新藥物輸送系統的需求增加，磷脂醯膽鹼提高生物利用度和穩定性的能力使其成為製藥製造商的首選成分。此外，正在進行的研究和開發工作可能會擴大其應用，從而加強其在製藥領域的突出地位。

北美磷脂醯膽鹼產業在 2023 年累計達到 4.701 億美元，在消費者對健康和保健日益重視的推動下，到 2032 年將以 6.5% 的複合年成長率成長。該地區強大的製藥業推動了各種治療應用（包括膳食補充劑和功能性食品）對高品質磷脂醯膽鹼的需求。此外，人們越來越認知到該成分對肝臟健康和認知功能的益處，進一步提高了其受歡迎程度。憑藉支持清潔標籤產品的強大監管框架，北美仍然是磷脂醯膽鹼市場整體成長的重要貢獻者。

產業生態系統分析
- 主要製造商
- 經銷商
- 全行業利潤率
產業影響力
- 成長動力
- 市場挑戰
- 市場機會
  - 新機遇
  - 成長潛力分析
原料景觀
- 製造趨勢
- 技術演進
  - 永續製造
    - 綠色實踐
    - 脫碳
- 原料的永續性
- 價格趨勢（美元/噸），2021 - 2032
法規和市場影響
波特的分析
PESTEL分析

第 4 章：競爭格局

公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場規模與預測：按來源分類，2021-2032 年

主要趨勢
大豆
向日葵
蛋黃
油菜籽
其他（芥末、棉籽）

第 6 章：市場規模與預測：按形式分類，2021-2032 年

主要趨勢
液體
粉末
顆粒劑

第 7 章：市場規模與預測：按應用分類，2021-2032 年

主要趨勢
藥品
膳食補充劑
化妝品和個人護理
食品和飲料
其他（動物營養及工業應用）

第 8 章：市場規模與預測：按地區分類，2021-2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
MEA
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 南非
- MEA 的其餘部分

第 9 章：公司簡介

Amitex Agro Product Pvt. Ltd.
Creative Biolabs
Croda International Plc
Fengchen Group Co., Ltd
Lipoid GmbH
Merck KGaA
MITUSHI BIO PHARMA
Rajvi Enterprise
SimSon Pharma Limited

簡介目錄

Product Code: 11157

The Global Phosphatidylcholine Market garnered USD 1.3 billion in 2023 and will grow at 6% CAGR from 2024 to 2032, spurred by heightened consumer awareness of health and wellness coupled with advancements in pharmaceutical applications and a growing demand for dietary supplements. As individuals increasingly prioritize their health, they seek effective supplements that support cognitive function, liver health, and overall well-being. Moreover, advancements in research and technology are expanding the applications of phosphatidylcholine in pharmaceuticals, enhancing its therapeutic potential. This convergence of health consciousness and innovative applications positions phosphatidylcholine as a key ingredient in the evolving wellness landscape.

The phosphatidylcholine industry is segmented based on source, form, application, and region.

The soybean segment held USD 578.3 million in 2023 and will expand at a 6.5% CAGR during 2024-2032, driven by its widespread availability and cost-effectiveness. Soybean-derived phosphatidylcholine is favored for its established applications in dietary supplements and pharmaceuticals, making it a popular choice among manufacturers. As health-conscious consumers increasingly seek affordable and effective supplements, the demand for soybean-based products continues to rise. Besides, the growing emphasis on non-GMO and allergen-free ingredients further enhances the appeal of soybean phosphatidylcholine, solidifying its dominant position in the market.

The pharmaceuticals segment was expanded to USD 477.3 million in 2023 and gain a 6.8% CAGR from 2024 to 2032, fueled by its critical role in various therapeutic applications. Phosphatidylcholine is recognized for its high purity and effectiveness in formulations targeting liver health, cognitive function, and cell membrane integrity. As the demand for innovative drug delivery systems increases, phosphatidylcholine's ability to enhance bioavailability and stability makes it a preferred ingredient among pharmaceutical manufacturers. Also, ongoing research and development efforts are likely to expand its applications, reinforcing its prominence in the pharmaceutical segment.

North America phosphatidylcholine industry accumulated USD 470.1 million in 2023 and will grow at a 6.5% CAGR till 2032, fueled by a growing emphasis on health and wellness among consumers. The region's strong pharmaceutical sector drives demand for high-quality phosphatidylcholine in various therapeutic applications, including dietary supplements and functional foods. Additionally, increasing awareness of the ingredient's benefits for liver health and cognitive function further boosts its popularity. With a robust regulatory framework supporting clean-label products, North America remains a significant contributor to the overall growth of the phosphatidylcholine market.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Base estimates and calculations
1.3 Forecast calculation
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Key manufacturers
- 3.1.2 Distributors
- 3.1.3 Profit margins across the industry
3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.2 Market challenges
- 3.2.3 Market opportunity
  - 3.2.3.1 New opportunities
  - 3.2.3.2 Growth potential analysis
3.3 Raw material landscape
- 3.3.1 Manufacturing trends
- 3.3.2 Technology evolution
  - 3.3.2.1 Sustainable manufacturing
    - 3.3.2.1.1 Green practices
    - 3.3.2.1.2 Decarbonization
- 3.3.3 Sustainability in raw materials
- 3.3.4 Pricing trends (USD/Ton), 2021 - 2032
  - 3.3.4.1 North America
  - 3.3.4.2 Europe
  - 3.3.4.3 Asia Pacific
  - 3.3.4.4 Latin America
  - 3.3.4.5 Middle East and Africa
3.4 Regulations and market impact
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Company market share analysis
4.2 Competitive positioning matrix
4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Source, 2021-2032 (USD Million, Tons)

5.1 Key trends
5.2 Soybean
5.3 Sunflower
5.4 Egg Yolk
5.5 Rapeseed
5.6 Others (mustard and cottonseed)

Chapter 6 Market Size and Forecast, By Form, 2021-2032 (USD Million, Tons)

6.1 Key trends
6.2 Liquid
6.3 Powder
6.4 Granules

Chapter 7 Market Size and Forecast, By Application, 2021-2032 (USD Million, Tons)

7.1 Key trends
7.2 Pharmaceuticals
7.3 Dietary supplements
7.4 Cosmetics and personal care
7.5 Food and beverages
7.6 Others (animal nutrition and industrial application)

Chapter 8 Market Size and Forecast, By Region, 2021-2032 (USD Million, Tons)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 Australia
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 MEA
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 South Africa
- 8.6.4 Rest of MEA